Learn More


 
MBA Tools
MBA Glossary

 


Santarus, Inc. - SNTS - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

 

Santarus, Inc. - SIC # 2834

Ticker Exchange SIC # Website Latest Ticker
SNTS Nasdaq 2834 http://www.santarus.com 22.56 Stock Down -0.37

Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company:

Latest Headlines for Santarus, Inc.

Oncogenex to Advance OGX-427 Development - May 24th, 2013 1:40 pm
New Diagnostic Solution from Roche - May 24th, 2013 9:00 am
Pfizer Halts Inotuzumab Study - May 23rd, 2013 4:20 pm
Impax Launches Generic Zomig - May 23rd, 2013 3:40 pm
Data on AstraZeneca's Naloxegol - May 23rd, 2013 3:30 pm
Repros to Conduct Phase IIb Trial - May 23rd, 2013 3:05 pm
Ironwood Pharma Prices Stock Offering - May 23rd, 2013 9:35 am
Bull of the Day: Santarus - May 22nd, 2013 4:03 pm
Data on Merck KGaA's L-BLP25 - May 22nd, 2013 2:30 pm
Data on UCB's Neupro - May 22nd, 2013 2:25 pm
XenoPort Resumes Horizant Supply - May 22nd, 2013 2:20 pm
Sanofi/REGN's Dupilumab Data Published - May 22nd, 2013 2:00 pm
FDA Designation for Synageva Candidate - May 22nd, 2013 1:50 pm
Swiss Issue for AMAG/Takeda's Rienso - May 22nd, 2013 1:35 pm
Additional Patent for Acorda's Ampyra - May 22nd, 2013 12:55 pm
Generic Launches at Mylan Continue - May 22nd, 2013 12:45 pm


View All Current Headlines >>

Bookmark and Share
facebooktwitter